loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 203496 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    United Therapeutics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TREPROSTINIL DIOLAMINE (5)

    filter

    01 UNITED THERAP (5)

    filter

    01 TABLET, EXTENDED RELEASE;ORAL (5)

    filter

    01 EQ 0.125MG BASE (1)

    02 EQ 0.25MG BASE (1)

    03 EQ 1MG BASE (1)

    04 EQ 2.5MG BASE (1)

    05 EQ 5MG BASE (1)

    filter

    01 USA (5)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Treprostinil Diolamine

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED RELEA...
    EQ 2.5MG BASE
    ORENITRAM
    USA
    203496
    2013-12-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Treprostinil Diolamine

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED RELEA...
    EQ 0.25MG BASE
    ORENITRAM
    USA
    203496
    2013-12-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Treprostinil Diolamine

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED RELEA...
    EQ 5MG BASE
    ORENITRAM
    USA
    203496
    2016-10-07
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Treprostinil Diolamine

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED RELEA...
    EQ 1MG BASE
    ORENITRAM
    USA
    203496
    2013-12-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Treprostinil Diolamine

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, EXTENDED RELEA...
    EQ 0.125MG BASE
    ORENITRAM
    USA
    203496
    2013-12-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 203496

    Looking for CTD TGA MCC DOSSIER APPLICATION 203496 5

    19

    United Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is TREPROSTINIL DIOLAMINE, with a corresponding application number 203496 and regulatory information .

    proudly manufactured in the

    approval since 2013-12-20

    United Therapeutics's ORENITRAM TABLET, EXTENDED RELEASE;ORAL, medication with EQ 2.5MG BASE of TREPROSTINIL DIOLAMINE.

    18

    United Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is TREPROSTINIL DIOLAMINE, with a corresponding application number 203496 and regulatory information .

    proudly manufactured in the

    approval since 2013-12-20

    United Therapeutics's ORENITRAM TABLET, EXTENDED RELEASE;ORAL, medication with EQ 0.25MG BASE of TREPROSTINIL DIOLAMINE.

    17

    United Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is TREPROSTINIL DIOLAMINE, with a corresponding application number 203496 and regulatory information .

    proudly manufactured in the

    approval since 2016-10-07

    United Therapeutics's ORENITRAM TABLET, EXTENDED RELEASE;ORAL, medication with EQ 5MG BASE of TREPROSTINIL DIOLAMINE.

    16

    United Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is TREPROSTINIL DIOLAMINE, with a corresponding application number 203496 and regulatory information .

    proudly manufactured in the

    approval since 2013-12-20

    United Therapeutics's ORENITRAM TABLET, EXTENDED RELEASE;ORAL, medication with EQ 1MG BASE of TREPROSTINIL DIOLAMINE.

    15

    United Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is TREPROSTINIL DIOLAMINE, with a corresponding application number 203496 and regulatory information .

    proudly manufactured in the

    approval since 2013-12-20

    United Therapeutics's ORENITRAM TABLET, EXTENDED RELEASE;ORAL, medication with EQ 0.125MG BASE of TREPROSTINIL DIOLAMINE.

    Post Enquiry
    POST ENQUIRY